Share this article
Share this article
FRANKLIN LAKES, N.J., April 1, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the U.S. Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) for its rapid antigen test to be used for SARS-CoV-2 screening through serial testing of asymptomatic individuals.
BD today announced the FDA has granted Emergency Use Authorization (EUA) for its BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2 to be used for SARS-CoV-2 screening through serial testing of asymptomatic individuals.
An elementary school student is receives a rapid antigen test using the BD Veritor™ Plus System for Rapid Detection of SARS-CoV-2.
BD Receives Emergency Use Authorization for Asymptomatic Screening for SARS-CoV-2 through Serial Rapid Antigen Testing
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Architecture as Art: Good Idea or Very Bad Idea?
archinect.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from archinect.com Daily Mail and Mail on Sunday newspapers.
Since the COVID-19 pandemic began, the Irish pub popular for its live music has adapted and changed more than once to adhere to state guidelines all without losing a beat. That will continue this St. Patrick’s Day with a full day of music being played in a way that has never happened on the holiday at O’Shea’s.
“Prior to COVID hitting, we had gone approximately 13 years of having music every night of the year, without exception,” says Mark Sullivan, a bartender at O’Shea’s. “There were no nights missed.”
Since Jan. 12, that nightly music has been virtual. Sullivan has been showing nightly live-streams of local bands performing. He uses a projector on a 100-inch screen, making the bands look “life-like.” The audio goes through the house system.
BD Announces Collaboration with ImageMover for Rapid Antigen Test Reporting
Reporting app helps facilitate SARS-CoV-2 testing and result reporting from BD Veritor™ Plus System
News provided by
Share this article
Share this article
FRANKLIN LAKES, N.J., March 9, 2021 /PRNewswire/ BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced an agreement with ImageMover, a software platform that automates and simplifies medical data collection and management, to offer a companion mobile app that enables more streamlined reporting of SARS-CoV-2 antigen testing results performed on the BD Veritor™ Plus System at everyday testing locations, such as schools and businesses. The ImageMover app is available immediately for BD Veritor™ Plus System customers.